OBI forfeits subscription of AP Biosciences’ cash capital increase, distributes rights to its shareholders and sets target date

1.Date of occurrence of the event:2022/08/08 2.Company name:OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence:To be conducted by the Board of Directors’ resolution on 2022/08/08. 6.Countermeasures:None 7.Any other matters that need to be specified: (1)The Company decides to forfeit all the preemptive […]

This article is password protected.

To view the content, please enter your password in the field below